In a medical breakthrough, a new approach to immunotherapy has led to complete regression of breast cancer in a patient unresponsive to all other treatments.
Browsing: Taxonomy > Metastasis
Researchers have discovered a potential new method of stopping metastasis by simultaneously inhibiting IL-6 and IL-8 paracrine signalling pathways.
Researchers have demonstrated that pre-invasive breast cancer cells undergo a stiffening state, through actin-stress fiber organization, prior to becoming malignant.
This article provides a immunotherapy perspective of Ipilimumab, a CTLA-4-targeted monoclonal antibody, reviewing drug mechanism, blockade, combination therapies and future prospectives.
The largest-known study in thyroid cancer patients highlights that skeletal complications in high-risk follicular and medullary thyroid cancer patients are an indicator of poor prognosis.
Selective Internal Radiation Therapy (SIRT) or transarterial radioembolisation (TARE) involves injection of 90Y-containing microspheres through the hepatic artery into liver…
Researchers have identified that inhibiting CDK4/6 signaling with an US FDA approved drug may inhibit the spread of triple-negative breast cancer.
Join us as we look back at 2016 on Oncology Central, reviewing some of the topics and data within oncology that really got you talking over the course of the last year.
Dr Hafez Halawani talks to Oncology Central regarding the predictive and prognostic potential of tumor location in metastatic colorectal cancer – a debate that was perpetuated with the presentation of the Venook et al study at the 2016 ASCO meeting.
A pro-metastatic protein interaction has been identified in lung cancer and could present a potential future target.